Globe24h logo
 
 

Deficient management leads INDITEX on the verge of fail

BUCHAREST, ROMANIA - Zara wants to cover losses from theft with employees’ money.

The management, theft and losses give headaches to the Spanish group INDITEX, the owner of the ZARA chain. Only 10 months before, on July 25th, 2011, the publication Ziarul Financiar announced the fact that “INDITEX takes the manager from the Douglas perfumeries” pointing at Paul Cuza, who previously had the function of General Manager for Parfumerie Douglas SRL. Currently, the Romanian INDITEX group performs salary and structural changes without precedent, which the management team from Bucharest doesn’t want to explain.

The problem of the clothes theft is a known phenomenon, especially when it comes to expensive brands such as ZARA or Massimo Dutti. The phenomenon was publicly recognized even by the management of the INDITEX Group Romania, two years before. Probably worried by this fact, Mihai Cioltea, the development manager of the INDITEX Group from Romania, also named by the press as “the Zara man”, stated in 2010 for the economic website InCont the following: “They steal a lot. Only for the stores in Bucharest we have 10 cases of stealing per day, which we discover and, depending on the severity, we call the police”.[...]

Read the rest of the article...
 


    
back to index                    contact: globe @ globe24h.com





We respect intellectual property rights and will take appropriate steps to protect these rights.
If you believe your copyright has been infringed on, please send us a message with the following information:
1. An identification of the copyrighted work that you claim has been infringed
2. A link to the material located on Globe24h.com that you claim is a copyright infringement
3. Information on how to contact you including your address, telephone number, and email address.
Please send your message to: copyright @ globe24h.com


SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549

FORM 10-Q

(Mark One)

[ X ] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934

For the quarterly period ended December 29, 1996

Or

[ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934

For the transition period from to

Commission file number 0-20028

VALENCE TECHNOLOGY, INC.
(Exact name of registrant as specified in its charter)

            Delaware                                   77-0214673
- ------------------------------------     ---------------------------------------
  (State or other jurisdiction of          (I.R.S. Employer Identification No.)
   incorporation or organization)

301 Conestoga Way, Henderson, Nevada 89015

(Address of prinicpal executive offices including zip code)

(702) 558-1000

(Registrant's telephone number, including area code)


Former name, former address and former fiscal year, if changed since last report

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

(1) Yes X No (2) Yes X No

Indicate the number of shares outstanding of each of the issuer's classes of common stock, as of the latest practicable date.

       Common Stock $0.001 par value                    21,713,793 shares
- --------------------------------------------   ---------------------------------
                 (Class)                       (Outstanding at February 3, 1997)


VALENCE TECHNOLOGY, INC. AND SUBSIDIARIES
(COMPANIES IN THE DEVELOPMENT STAGE)

FORM 10-Q

FOR THE QUARTER ENDED DECEMBER 29, 1996

                                        INDEX

                                                                           Pages
                                                                           -----
PART I.    FINANCIAL INFORMATION

  Item 1.  Financial Statements:

           Condensed Consolidated Balance Sheets as of
           December 29, 1996 and March 31, 1996..............................3

Condensed Consolidated Statements of Operations for the period from March 3, 1989 (date of inception) to December 29, 1996 and for each of the three months and nine months ended December 29, 1996 and December 24, 1995..............4

Condensed Consolidated Statements of Cash Flows for the period from March 3, 1989 (date of inception) to December 29, 1996 and for each of the nine months ended December 29, 1996 and December 24, 1995.....................5

Notes to Consolidated Financial Statements........................6

Item 2. Managements Discussion and Analysis of Financial Condition and Results of Operations...............................8

PART II. OTHER INFORMATION

Item 4. Submission of Matters to a Vote of Security Holders..............11

Item 6. Exhibits and Reports on Form 8-K.................................11

SIGNATURES

2

VALENCE TECHNOLOGY, INC. AND SUBSIDIARIES
(COMPANIES IN THE DEVELOPMENT STAGE)

CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands, except per share amounts)

(unaudited)

                                                                          December 29,                  March 31,
                                                                              1996                        1996
                                                                        ----------------              -------------

                            ASSETS
Current assets:
  Cash and cash equivalents                                                 $ 32,900                    $ 24,569
  Short-term investments                                                       6,420                      26,492
  Accounts receivable                                                            577                         545
  Interest receivable                                                            254                         444
  Prepaids and other current assets                                              214                         299
                                                                            --------                    --------

      Total current assets                                                    40,365                      52,349

Investments                                                                    4,000                       5,790
Property, plant and equipment, net                                            12,385                      11,752
Other assets                                                                   1,087                         356
                                                                            --------                    --------

        Total assets                                                        $ 57,837                    $ 70,247
                                                                            --------                    --------
                                                                            --------                    --------

                         LIABILITIES

Current liabilities:
  Current portion of long-term debt                                         $  1,851                    $  2,277
  Accounts payable                                                             1,629                       1,251
  Accrued expenses                                                             5,279                       6,180
  Accrued compensation                                                         1,658                       1,360
                                                                            --------                    --------

      Total current liabilities                                               10,417                      11,068

Long-term debt, less current portion                                           5,091                       6,169
                                                                            --------                    --------

        Total liabilities                                                     15,508                      17,237

Contingencies (Note 3).

                    STOCKHOLDERS' EQUITY

Preferred stock, $0.001 par value:
  Authorized:  10,000 shares;
  Issued and outstanding:  none

Common stock, $0.001 par value:
  Authorized:  50,000 shares;
  Issued and outstanding: 21,673 and 21,665 shares at
  December 29, 1996 and March 31, 1996, respectively                         140,338                     140,307
Deficit accumulated during the development stage                             (99,063)                    (87,638)
Cumulative translation adjustment                                              1,054                         341
                                                                            --------                    --------

      Total stockholders' equity                                              42,329                      53,010
                                                                            --------                    --------

        Total liabilities and stockholders' equity                          $ 57,837                    $ 70,247
                                                                            --------                    --------
                                                                            --------                    --------

The accompanying notes are an integral part of these consolidated financial statements

3

VALENCE TECHNOLOGY, INC. AND SUBSIDIARIES
(COMPANIES IN THE DEVELOPMENT STAGE)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands, except per share amounts)

(unaudited)

                                  Period from
                                 March 3, 1989
                              (date of inception)
                                    through                    Three Months Ended                       Nine Months Ended
                                                        --------------------------------       --------------------------------
                                  December 29           December 29,        December 24,       December 29,        December 24,
                                      1996                  1996                1995               1996                1995
                            -----------------------     ------------        ------------       ------------        ------------

Revenue:
  Research and development
    contracts                     $  21,605               $     0             $     0            $      0            $      0
                                  ---------               -------             -------            --------            --------

Costs and expenses:
  Research and development           67,034               $ 3,570               1,363            $  8,810               5,531
  Marketing                           2,624                    29                  90                 152                 383
  General and administrative         30,317                 1,695               1,439               4,122               3,921
  Purchase of in-process
    technology                        8,212                     -                   -                   -               6,064
  Investment in Danish
    subsidiary                        3,489                     -                   -                   -                   -
  Special charges                    18,872                     -                   -                   -                   -
                                  ---------               -------             -------            --------            --------

    Total costs and expenses        130,548                 5,294               2,892              13,084              15,899
                                  ---------               -------             -------            --------            --------

      Operating loss               (108,943)               (5,294)             (2,892)            (13,084)            (15,899)

Interest income                      13,253                   631                 912               2,084               2,642
Interest expense                     (3,737)                 (139)               (172)               (425)               (716)
                                  ---------               -------             -------            --------            --------

        Net loss                  $ (99,063)              $(4,802)            $(2,152)           $(11,425)           $(13,973)
                                  ---------               -------             -------            --------            --------
                                  ---------               -------             -------            --------            --------

Net loss per share                $       -               $ (0.22)            $ (0.11)           $  (0.53)           $  (0.69)
                                  ---------               -------             -------            --------            --------
                                  ---------               -------             -------            --------            --------

Shares used in computing
  net loss per share                      -                21,673              20,134              21,672              20,160
                                  ---------               -------             -------            --------            --------
                                  ---------               -------             -------            --------            --------

The accompanying notes are an integral part of these consolidated financial statements

4

VALENCE TECHNOLOGY, INC. AND SUBSIDIARIES
(COMPANIES IN THE DEVELOPMENT STAGE)

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands, except per share amounts)

(unaudited)

                                                           Period from
                                                          March 3, 1989               Nine Months             Nine Months
                                                       (date of inception)             Ended                   Ended
                                                             through                  December 29,            December 24,
                                                        December 29, 1996                1996                    1995
                                                     -----------------------         ------------            -------------
Cash flows from operating activities:
  Net loss                                                 $ (99,063)                 $ (11,425)              $ (13,973)
  Adjustments to reconcile net loss to net cash
    used in operating activities:
    Depreciation and amortization                             18,927                      2,618                   2,900
    Write-off of equipment                                    14,767                          -                  (1,085)
    Write-off of in-process technology                         8,212                          -                   8,064
    Compensation related to stock options                      1,451                         30                       -
    Noncash charge related to acquisition of
      Danish subsidiary                                        2,245                          -                       -
    Changes in assets and liabilities:
      Accounts receivable                                        512                        (32)                   (280)
      Interest receivable                                       (246)                       192                       1
      Notes receivable                                           115                        258                    (146)
      Prepaid expenses and other current assets               (2,157)                      (899)                     85
      Accounts payable                                         1,528                        378                  (1,431)
      Accrued liabilities                                     (1,350)                      (604)                 (1,270)
                                                           ---------                  ---------               ---------

        Net cash used in operating activities                (55,059)                    (9,484)                 (7,135)
                                                           ---------                  ---------               ---------

Cash flows from investing activities:
  Purchase of in-process technology                           (2,001)                         0                  (2,001)
  Purchases of long-term investments                        (685,348)                  (288,259)               (126,082)
  Maturities of long-term investments                        676,061                    311,255                 134,296
  Capital expenditures                                       (38,913)                    (3,040)                   (441)
  Other                                                         (222)                         0                       0
                                                           ---------                  ---------               ---------

        Net cash provided by (used in)
          investing activities                               (50,423)                    19,956                   5,772
                                                           ---------                  ---------               ---------

Cash flows from financing activities:
  Property and equipment grants                                4,322                         28                     675
  Borrowings of long-term debt                                15,502                          -                       -
  Payments of long-term debt:
    Product development loan                                    (482)                         -                       -
    Shareholder and director                                  (6,173)                         -                       -
    Other long-term debt                                     (10,244)                    (1,505)                 (2,503)
  Proceeds from issuance of common stock,
    net of costs                                             136,511                          0                     179
                                                           ---------                  ---------               ---------

        Net cash provided by (used in)
          financing activities                               139,436                     (1,477)                 (1,649)
                                                           ---------                  ---------               ---------

Effect of foreign exchange rates on cash and cash
  equivalents                                                 (1,054)                      (664)                   (321)

Increase (decrease) in cash and cash equivalents              32,900                      8,331                  (3,333)
Cash and cash equivalents, beginning of period                     0                     24,569                  16,602
                                                           ---------                  ---------               ---------
Cash and cash equivalents, end of period                   $  32,900                  $  32,900               $  13,269
                                                           ---------                  ---------               ---------
                                                           ---------                  ---------               ---------

The accompanying notes are an integral part of these consolidated financial statements

5

VALENCE TECHNOLOGY, INC. AND SUBSIDIARIES
(COMPANIES IN THE DEVELOPMENT STAGE)

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except per share amounts)

(unaudited)

1. Interim Condensed Consolidated Financial Statements

These interim condensed consolidated financial statements are unaudited but reflect, in the opinion of management all normal recurring adjustments necessary to present fairly the financial position of Valence Technology, Inc. and Subsidiaries (the Company) as of December 29, 1996 and March 31, 1996, its consolidated results of operations and cash flows for the period from March 3, 1989 (date of inception) to December 29, 1996 and for each of the three-month and nine-month periods ended December 29, 1996 and December 24, 1995. Because all the disclosures required by generally accepted accounting principles are not included, these interim condensed consolidated financial statements should be read in conjunction with the audited financial statements and notes thereto in the Company's Annual Report on Form 10-K as of and for the year ended March 31, 1996. The year end condensed consolidated balance sheet data as of March 31, 1996 was derived from audited financial statements, but does not include all disclosures required by generally accepted accounting principles.

The results of operations for the three-month and nine-month periods and the cash flows for the nine-months ended December 29, 1996 are not necessarily indicative of results of operations and cash flows for any future period.

2. Net Loss Per Share

The computation of net loss per share is based on the weighted average number of common shares outstanding during the period. Common stock options and warrants have not been included in the computation since their inclusion would be antidilutive.

3. Contingencies

LITIGATION

In May 1994, a series of class action lawsuits were filed in the United States District Court for the Northern District of California against the Company and certain of its present and former officers and directors. These lawsuits were consolidated, and in September 1994 the plaintiffs filed a consolidated and amended class action complaint. Following the Court's Orders on motions to dismiss the complaint, which were granted in part and denied in part, the plaintiffs filed an amended complaint in October 1995 ("Complaint"). The Complaint alleges violations of the federal securities laws against the Company, certain of its present and former officers and directors, and the underwriters of the Company's public stock offerings, claiming that the defendants issued a series of false and misleading statements, including filings with the Securities and Exchange Commission, with regard to the Company's business and future prospects. The plaintiffs seek to represent a class of persons who purchased the Company's common stock between May 7, 1992 and August 10, 1994. The Complaint seeks unspecified compensatory and punitive damages, attorney's fees and costs. On January 23, 1996, the Court dismissed, with prejudice, all claims against the underwriters of the Company's public stock offerings, and one claim against the Company and its present and former officers and directors. On April 29, 1996, the Court dismissed with prejudice all remaining claims against a present director and limited claims against a former officer and director to the period when the person was an officer. The Company believes it has meritorious defenses and intends to defend the lawsuit vigorously.

The ultimate outcome of these actions cannot presently be determined. Accordingly, no provision for any liability or loss that may result from adjudication or settlement thereof has been made in the accompanying consolidated financial statements.

6

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(continued)

4. Recent Accounting Pronouncements

During March 1995, the Financial Accounting Standards Board issued Statement No. 121, Accounting for the Impairment of Long-Lived Assets and for Long-Lived Assets to Be Disposed Of, which requires the Company to review for impairment of long-lived assets, certain identifiable intangibles, and goodwill related to those assets whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. In certain situations, an impairment loss would be recognized. It will be effective for the Companys fiscal year 1996. The Company has studied the implications of the statement, and based on its initial evaluation, does not expect it to have a material impact on the Companys financial condition or results of operations.

During October 1995, the Financial Accounting Standards Board issued Statement No. 123 (SFAS No. 123), Accounting for Stock-Based Compensation, which establishes a fair value based method of accounting for stock-based compensation plans. The Company is currently following the requirements of APB Opinion No. 25, Accounting for Stock Issued to Employees while it studies the implications of SFAS No. 123 and evaluates the effect, if any, on the financial condition and results of operations of the Company. SFAS No. 123 will be effective for the Companys fiscal year 1996.

7

ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

In addition to the historical information contained herein, the following discussion contains forward looking statements that involve risk and uncertainties. The Companys actual results may differ materially from those discussed herein. Factors that could cause or contribute to such differences include, but are not limited to, those discussed in this section of the Companys Annual Report on Form 10-K for the year ended March 31, 1996.

OVERVIEW

The Company was founded in 1989 to develop and commercialize advanced rechargeable batteries based on lithium and polymer technologies. Since its inception, the Company has been a development stage company primarily engaged in acquiring and developing its initial technology, manufacturing limited quantities of prototype batteries recruiting personnel, and acquiring capital. To date, other than insubstantial revenues from limited sales of prototype batteries, the Company has not received any significant revenues from the sale of products. Substantially all revenues to date have been derived from a research and development contract with the Delphi Automotive Systems Group (Delphi, formerly the Delco Remy Division), and operating group of the General Motors Corporation. The Company has incurred cumulative losses of $99,063,000 from its inception to December 29, 1996.

This Management's Discussion and Analysis of Financial Condition and Results of Operations should be read in conjunction with the accompanying condensed consolidated financial statements and notes thereto contained herein and the Company's consolidated financial statements and notes thereto contained in the Company's Annual Report on Form 10-K as of and for the year ended March 31, 1996.

RESULTS OF OPERATIONS

THREE AND NINE MONTHS ENDED DECEMBER 29, 1996 AND DECEMBER 24, 1995 (THIRD QUARTER AND FIRST NINE MONTHS OF FISCAL 1997 AND FISCAL 1996, RESPECTIVELY).

During the three and nine months ended December 29, 1996, the Company continued development activities under a research and development agreement with Delphi. Payments were generally made in accordance with the achievement of certain milestones. No revenues were recognized during the third quarter and first nine months of fiscal 1997.

In September, 1994 the Company and Delphi signed a new five year agreement to combine efforts in developing the Company's rechargeable solid state lithium polymer battery technology. Under the agreement, Delphi and the Company combined their research and development activities in a new facility in Henderson, Nevada. The new facility is owned by the Company, with Delphi paying a fee of $50,000 per month over the five year term of the new agreement for access to the Company's research and development (of which $150,000 and $450,000 were recognized during the third quarter and nine months of fiscal 1997, respectively, as an offset to research and product development expenses). In addition, Delphi is paying a majority of the facility's operating costs over the term of the new five year agreement. The Company is treating both of these payments as an offset to research and development expense.

Research and development expenses were $3,570,000 and $8,810,000 during the three and nine months ended December 29, 1996 as compared to $1,363,000 and $5,531,000 during the same periods of fiscal 1996. The increase between comparable periods was primarily due to costs incurred to proceed with manufacturing product in the first half of calendar year 1997.

Marketing expenses were $29,000 and $152,000 for the third quarter and nine months of fiscal year 1997, respectively, as compared to $90,000 and $383,000 during similar periods of fiscal year 1996. The comparative decrease is the result of a reduction in headcount, relocation and travel expenses.

General and administrative expenses increased to $4,122,000 during fiscal 1997s first nine months, up from $3,921,000 during the first nine months of fiscal 1996. The year to year change primarily reflects an increase in payroll and professional services spending. For the third quarter, general and administrative expenses increased to

8

$1,695,000 from $1,439,000 last year primarily as a result of increased legal expenses and reduction in other income associated with the liquidation of our Danish subsidiary in fiscal 1996.

Interest income decreased to $631,000 and $2,084,000 during the third quarter and nine months of fiscal year 1997, respectively, as compared to $912,000 and $2,642,000 during the prior fiscal year's same periods. The difference is a result of fewer funds available for investment purposes.

Interest expense was $139,000 and $425,000 during the third quarter and nine months of fiscal year 1997, respectively, as compared to $172,000 and $716,000 during the prior fiscal year's comparable periods. This decrease is a result of reduction in long-term debt outstanding.

LIQUIDITY AND CAPITAL RESOURCES

The Company used $9,484,000 net cash for operating activities during fiscal year 1997's first nine months whereas it used $7,135,000 during the first nine months of fiscal year 1996, an increase between comparable periods of $2,349,000. This net increase primarily resulted from costs associated with the product commercialization activities.

During the nine months ended December 29, 1996, the Company provided $19,956,000 net cash from investing activities compared to $5,772,000 provided during the first nine months of fiscal year 1996, an increase of $14,184,000 between comparable periods. The increase primarily was a result of shortened investment maturities, resulting in reclassification to cash and cash equivalents.

The Company used $1,477,000 net cash from financing activities during fiscal year 1997's first nine months versus using $1,649,000 during the first nine months of fiscal year 1996. This decrease resulted from lower grant levels and reduced debt repayments.

As a result of the above, the Company had a net increase in cash and cash equivalents of $8,331,000 during the fiscal year 1997's first nine months, whereas it had a net decrease of $3,333,000 during the same period of fiscal year 1996.

The Company's $2,000,000 working capital line of credit is available through March, 1997. The working capital line collateralizes outstanding letters of credit, which reduce borrowings otherwise available under the line. As of December 29, 1996, there are outstanding letters of credit in the amount of $1,375,000 to assure delivery of raw materials for product commercialization.

During fiscal year 1994, the Company through its Dutch subsidiary, signed an agreement with the Northern Ireland Industrial Development Board (IDB) to open an automated manufacturing plant in Northern Ireland in exchange for capital and revenue grants from the IDB. The Company has also received offers from the IDB to receive additional grants. The grants available under the agreement and offers, for an aggregate of up to 27,555,000, generally become available over a five year period through October 31, 1998. As of December 29, 1996, the Company had received grants aggregating 3,978,050 reducing remaining grants available to 23,576,950 (US. $39,885,000 as of December 29, 1996). The Company is in the process of negotiating an extension to the October 31, 1998 committment date from the IDB.

As a condition to receiving funding from the IDB, the subsidiary must maintain a minimum of 12,000,000 in debt or equity financing from the Company. Aggregate funding under the grants is limited to 4,035,000 until the Company has recognized $4,000,000 in aggregate revenue from the sale of its batteries produced in Northern Ireland. Given that the Company has no agreements to supply batteries using its current technology, there are no assurances that the Company will be able to meet the agreement's revenue test.

The amount of the grants available under the agreement and offers is primarily dependent on the level of capital expenditures made by the Company. Substantially all of the funding received under the grants is repayable to the IDB if the subsidiary is in default under the agreement and offers, which includes the permanent cessation of business in Northern Ireland. Funding received under the grants to offset capital expenditures is repayable if related equipment is sold, transferred or otherwise disposed of during a four year period after the date of grant. In addition, a portion of funding received under the grants may also be repayable if the subsidiary fails to maintain

9

specified employment levels for the two year period immediately after the end of the five year grant period. The Company has guaranteed the subsidiary's obligations to the IDB under the agreement.

There can be no assurance that the Company will be able to meet the requirements necessary for it to receive and retain grants under the IDB agreement and offers.

The Company expects that its existing funds as of December 29, 1996, together with the interest earned thereon, will be sufficient to fund the Company's operations through the end of fiscal year 1997 and into fiscal 1998. The Company anticipates that it may need substantial additional funds in the future for capital expenditures, research and product development, marketing and general and administrative expenses and to pursue joint venture opportunities. The Company's cash requirements, however, may vary materially from those now planned because of changes in the Company's operations, including changes in OEM relationships or market conditions. There can be no assurance that funds for these purposes, whether from equity or debt financing agreements with strategic partners or other sources, will be available on favorable terms, if at all.

Forward looking statments involve a number of risks and uncertaintites including, but not limited to, market acceptance, changing economic conditions, risks in product and technology development, effect of the Companys accounting policies and other risk factors detailed in the Companys Securities and Exchange Commission filings.

RECENT ACCOUNTING PRONOUNCEMENTS

During March 1995, the Financial Accounting Standards Board issued Statement No. 121, Accounting for the Impairment of Long-Lived Assets and for Long-Lived Assets to Be Disposed Of, which requires the Company to review for impairment of long-lived assets, certain identifiable intangibles, and goodwill related to those assets whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. In certain situations, an impairment loss would be recognized. It will be effective for the Companys fiscal year 1996. The Company has studied the implications of the statement, and based on its initial evaluation, does not expect it to have a material impact on the Companys financial condition or results of operations.

During October 1995, the Financial Accounting Standards Board issued Statement No. 123 (SFAS No. 123), Accounting for Stock-Based Compensation, which establishes a fair value based method of accounting for stock-based compensation plans. The Company is currently following the requirements of APB Opinion No. 25, Accounting for Stock Issued to Employees while it studies the implications of SFAS No. 123 and evaluates the effect, if any, on the financial condition and results of operations of the Company. SFAS No. 123 will be effective for the Companys fiscal year 1997.

10

Part II - OTHER INFORMATION

The discussion and analysis below, and throughout this report, contains forward looking statements within the meaning of Section 27A of the Securities and Exchange Act of 1934. Actual results could differ materially from those projected or suggested in the forward looking statements as a result of the risk factors set forth herein and in the Companys Annual Report on Form 10-K as of and for the year ended March 31, 1996.

ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

An annual meeting of the stockholders of the Company was held on January 31, 1997.

Companys stockholders elected the Boards nominees as directors by the votes indicated:

Nominee                  Votes For                 Votes Withheld
-------                  ---------                 --------------

Calvin L. Reed           18,048,277                   1,286,457
Carl E. Berg             18,046,110                   1,288,624
Alan F. Shugart          18,047,477                   1,287,257

The selection of Coopers & Lybrand as the Companys independent auditors was ratified with 18,976,410 votes in favor, 199,048 against and 159,276 abstentions.

The proposal to amend the 1990 Stock Option Plan to increase the aggregate number of shares of common stock authorized for issuance by 750,000 shares and to add provisions with respect to Section 162(m) of the Internal Revenue Code of 1986, as amended was ratified with 16,598,945 votes in favor, 2,285,725 against and 206,014 abstentions.

The proposal to adopt the 1996 Non-Employee Directors Stock Option Plan and the issuance of 250,000 shares of common stock under the plan was ratified with 15,021,733 votes in favor, 3,827,938 against and 241,013 abstentions.

ITEM 6. EXHIBITS AND REPORTS ON FORM 8-K

a.  Exhibits
    --------

    Exhibit 11.1   Statement of Calculation of Net Loss Per Share

    Exhibit 10.42  1990 Stock Option Plan

    Exhibit 10.43  1996 Non-Employee Directors Stock Option Plan

b. Reports on Form 8-K

The Company filed no reports on Form 8-K during the quarter ended December 29, 1996.

11

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereto duly authorized.

VALENCE TECHNOLOGY, INC.
(Registrant)

Date: February 7, 1997         By: /s/ David Archibald
                                  ------------------------------------------
                                  David Archibald
                                  Vice President and Chief Financial Officer
                                  (Principal Financial and Accounting Officer)

12

Exhibit 11.1
VALENCE TECHNOLOGY, INC. AND SUBSIDIARIES

(companies in the development stage)

STATEMENT OF CALCULATION OF NET LOSS PER SHARE
(Unaudited)

(in thousands, except per share amounts)

                                                             Three Months Ended                  Nine Months Ended
                                                      --------------------------------     ------------------------------
                                                      December 29,        December 24,     December 29,      December 24,
                                                          1996                1995             1996              1995
                                                      ------------        ------------     ------------      ------------
Actual weighted average shares of common stock
  outstanding for the period                             21,673              20,134           21,672             20,160

Net loss for period                                     $(4,802)            $(2,152)        $(11,425)          $(13,973)

Net loss per share for period                           $ (0.22)            $ (0.11)        $  (0.53)          $  (0.69)

Dilutive common stock warrants and stock options have not been included in the calculations of common and common equivalent shares to calculate net loss per share, as their inclusion would be antidilutive.

13

1990 STOCK OPTION PLAN

1. PURPOSE
a. The purpose of the Plan is to provide a means by which selected key employees and directors (if declared eligible under paragraph 4) of and consultants to Valence Technology, Inc., a Delaware corporation (the "Company"), and its Affiliates, as defined in subparagraph 1(b), may be given an opportunity to purchase stock of the Company.
b. The word "Affiliate" as used in the Plan means any parent corporation or subsidiary corporation of the Company, as those terms are defined in Sections 424(e) and (f), respectively, of the Internal Revenue Code of 1986, as amended from time to time (the "Code").
c. The Company, by means of the Plan, seeks to retain the services of persons now employed by or serving as consultants or directors to the Company, to secure and retain the services of new employees/persons capable of filling such positions, and to provide incentives for such persons to exert maximum efforts for the success of the Company.
d. The Company intends that the options issued under the Plan shall, in the discretion of the Board of Directors of the Company (the "Board") or any committee to which responsibility for administration of the Plan has been delegated pursuant to subparagraph 2(c), be either incentive stock options as that term is used in Section 422 of the Code ("Incentive Stock Options"), or options which do not qualify as incentive stock options ("Supplemental Stock Options"). All options shall be separately designated Incentive Stock Options or Supplemental Stock Options at the time of grant, and in such form as issued pursuant to paragraph 5, and a separate certificate or certificates shall be issued for shares purchased on exercise of each type of option. An option designated as a Supplemental Stock Option shall not be treated as an incentive stock option.

2. ADMINISTRATION
a. The Plan shall be administered by the Board unless and until the Board delegates administration to a committee, as provided in subparagraph 2(c). Whether or not the Board has delegated administration, the Board shall have the final power to determine all questions of policy and expediency that may arise in the administration of the Plan.
b. The Board shall have the power, subject to, and within the limitations of, the express provisions of the Plan:
(1) To determine from time to time which of the persons eligible under the Plan shall be granted options; when and how the option shall be granted; whether the option will be an Incentive Stock Option or a Supplemental Stock Option; the provisions of each option granted (which need not be identical), including the time or times during the term of each option within which all or portions of such option may be exercised; and the number of shares for which an option shall be granted to each such person.
(2) To construe and interpret the Plan options granted under it, and to establish, amend and revoke rules and regulations for its administration. The Board, in the exercise of this power, may correct any defect, omission or inconsistency in the Plan or in any option agreement, in a manner and to the extent it shall deem necessary or expedient to make the Plan fully effective.
(3) To amend the Plan as provided in paragraph 10.
(4) Generally, to exercise such powers and to perform such acts as the Board deems necessary or expedient to promote the best interests of the Company.
c. The Board may delegate administration of the Plan to a committee or committees ("Committee") of one or more members of the Board. In the discretion of the Board, a Committee may consist solely of two (2) or more Outside Directors, in accordance with Code Section 162(m), or solely of two
(2) or more Non-Employee Directors, in accordance with Rule 16b-3. If administration is delegated to a Committee, the Committee shall have, in connection with the administration of the Plan, the powers theretofore possessed by the Board (and references in this Plan to the Board shall thereafter be to the Committee), subject, however, to such resolutions, not inconsistent with the provisions of the Plan, as may

Page 1

be adopted from time to time by the Board. The Board may abolish the Committee at any time and revest in the Board the administration of the Plan.
d. "Non-Employee Director" means a director who either (I) is not a current employee or officer of the Company or its parent or subsidiary, does not receive compensation (directly or indirectly) from the Company or its parent or subsidiary for services rendered as a consultant or in any capacity other than as a director (except for an amount as to which disclosure would not be required under Item 404(a) of Regulation S-K promulgated pursuant to the Securities Act of 1933 ("Regulation S-K"), does not possess an interest in any other transaction as to which disclosure would be required under Item 404(a) of Regulation S-K, and is not engaged in a business relationship as to which disclosure would be required under Item 404(b) of Regulation S-K; or (ii) is otherwise considered a "non-employee director" for purposes of Rule 16b-3.
e. "Outside Director" means a director who either (I) is not a current employee of the Company or an "affiliated corporation" (within the meaning of Treasury regulations promulgated under Section 162(m) of the Code), is not a former employee of the Company or an "affiliated corporation" receiving compensation for prior services (other than benefits under a tax qualified pension plan), was not an officer of the Company or an "affiliated corporation" at any time, and is not currently receiving direct or indirect remuneration from the Company or an "affiliated corporation" for services in any capacity other than as a director, or (ii) is otherwise considered an "outside director" for purposes of Section 162(m) of the Code.

3. SHARES SUBJECT TO THE PLAN
a. Subject to the provisions of paragraph 9 relating to adjustments upon changes in stock, the stock that may be sold pursuant to options granted under the Plan shall not exceed in the aggregate Three Million Five Hundred Thousand (3,500,000) shares of the Company's common stock. If any option granted under the Plan shall for any reason expire or otherwise terminate without having been exercised in full, the stock not purchased under such option shall again become available for the Plan.
b. The stock subject to the Plan may be unissued reacquired shares, bought on the market or otherwise.
c. An Incentive Stock Option may be granted to an eligible person under the Plan only if the aggregate fair market value (determined at the time the option is granted) of the stock with respect to which incentive stock options (as defined in the Code) granted after 1986 are exercisable for the first time by such optionee during any calendar year under all incentive stock option plans of the Company and its Affiliates does not exceed one hundred thousand dollars ($100,000). Should it be determined that an option granted under the Plan exceeds such maximum for any reason other than the failure of a good faith attempt to value the stock subject to the option, such option shall be considered a Supplemental Stock Option to the extent, but only to the extent, of such excess; provided, however, that should it be determined that an entire option or any portion thereof does not qualify for treatment as an incentive stock option by reason of exceeding such maximum, such option or the applicable portion shall be considered a Supplemental Stock Option.

4. ELIGIBILITY
a. Incentive Stock Options may be granted only to employees (including officers) of the Company or its Affiliates. A director of the Company shall not be eligible to receive Incentive Stock Options unless such director is also an employee (including an officer) of the Company or any Affiliate. Supplemental Stock Options may be granted only to key employees (including officers) of, directors of or consultants to the Company or its Affiliates.
b. Subject to the provisions of Section 9 relating to adjustments upon changes in stock, no person shall be eligible to be granted options covering more than seven hundred thousand (700,000) shares of the Company's common stock in any fiscal year.
c. No person shall be eligible for the grant of an option under the Plan if, at the time of grant, such person owns (or is deemed to own pursuant to Section 424(d) of the Code) stock possessing more than ten percent (10%) of the total combined voting power of all classes of stock of the Company or of any of its Affiliates unless the exercise price of such option is at least one hundred ten percent (110%) of the fair market value of such stock at the date of grant and the term of the option does not exceed five (5) years from the date of grant.

Page 2

5. OPTION PROVISIONS Each option shall be in such form and shall contain such terms and conditions as the Board or the Committee shall deem appropriate. The provisions of separate options need not be identical, but each option shall include (through incorporation of provisions hereof by reference in the option or otherwise) the substance of each of the following provisions:
a. The term of any option shall not be greater than ten (10) years from the date it was granted.
b. The exercise price of each Incentive Stock Option shall be not less than one hundred percent (100%) of the fair market value of the stock subject to the option on the date the option is granted. The exercise price of each Supplemental Stock Option shall be not less than eighty-five percent (85%) of the fair market value of the stock subject to the option on the date the option is granted.
c. The purchase price of stock acquired pursuant to an option shall be paid, to the extent permitted by applicable statutes and regulations, either:
(i) in cash at the time the option is exercised, or
(ii) at the discretion of the Board or the Committee, either at the time of the grant or exercise of the option, (A) by delivery to the Company of other common stock of the Company, (B) according to a deferred payment or other arrangement (which may include, without limiting the generality of the foregoing, the use of other common stock of the Company) with the person to whom the option is granted or to whom the option is transferred pursuant to subparagraph 5(d), or
(C) in any other form of legal consideration that may be acceptable to the Board or the Committee. In the case of any deferred payment arrangement, interest shall be payable at least annually and shall be charged at the minimum rate of interest necessary to avoid the treatment as interest, under any applicable provisions of the Code, of any amounts other than amounts stated to be interest under the deferred payment arrangement.
d. An Incentive Stock Option shall not be transferable except by will or by the laws of descent and distribution, and shall be exercisable during the lifetime of the person to whom the Incentive Stock Option is granted only by such person. A Supplemental Stock Option may be transferred to the extent provided in the option agreement; provided that if the option agreement does not expressly permit the transfer of a Supplemental Stock Option, the Supplemental Stock Option shall not be transferable except by will, by the laws of descent and distribution or pursuant to a domestic relations order satisfying the requirements of Rule 16b-3, and shall be exercisable during the lifetime of the person to whom the option is granted only by such person or any transferee pursuant to a domestice relations order. Notwithstanding the foregoing, the person to whom the option is granted may, be delivering written notice to the Company, in a form satisfactory to the Company, designate a third party who, in the event of the death of the optionee, shall thereafter be entitled to exercise the option.e. The total number of shares of stock subject to an option may, but need not, be allotted in periodic installments (which may, but need not, be equal). From time to time during each of such installment periods, the option may become exercisable ("vest") with respect to some or all of the shares allotted to that period, and may be exercised with respect to some or all of the shares allotted to such period and/or any prior period as to which the option was not fully exercised. During the remainder of the term of the option (if its term extends beyond the end of the installment periods), the option may be exercised from time to time with respect to any shares then remaining subject to the option. The provisions of this subparagraph 5(e) are subject to any option provisions governing the minimum number of shares as to which an option may be exercised.
f. The Company may require any optionee, or any person to whom an option is transferred under subparagraph 5(d), as a condition of exercising any such option,
(1) to give written assurances satisfactory to the Company as to the optionee's knowledge and experience in financial and business matters and/or to employ a purchaser representative reasonably satisfactory to the Company who is knowledgeable and experienced in financial and business matters, and that he or she is capable of evaluating, alone or together with the purchaser representative, the merits and risks of exercising the option; and
(2) to give written assurances satisfactory to the Company stating that such person is acquiring the stock subject to the option for such person's own account and not with any present intention of selling or otherwise distributing the stock.

Page 3

These requirements, and any assurances given pursuant to such requirements, shall be inoperative if
(i) the issuance of the shares upon the exercise of the option has been registered under a then currently effective registration statement under the Securities Act of 1933, as amended (the "Securities Act"), or
(ii) as to any particular requirement, a determination is made by counsel for the Company that such requirement need not be met in the circumstances under the then applicable securities laws.
g. An option shall terminate three (3) months after termination of the optionee's employment or relationship as a consultant or director with the Company or an Affiliate, unless
(i) such termination is due to such person's permanent and total disability, within the meaning of Section 422 (c)(7) of the Code, in which case the option may, but need not, provide that it may be exercised at any time within one (1) year following such termination of employment or relationship as a consultant or director; or
(ii) the optionee dies while in the employ of or while serving as a consultant or director to the Company or an Affiliate, or within not more than three (3) months after termination of such relationship, in which case the option may, but need not, provide that it may be exercised at any time within eighteen (18) months following the death of the optionee by the person or persons to whom the optionee's rights under such option pass by will or by the laws of descent and distribution; or
(iii) the option by its terms specifies either
(a) that it shall terminate sooner than three (3) months after termination of the optionee's employment or relationship as a consultant or director, or
(b) that it may be exercised more than three (3) months after termination of such relationship with the Company or an Affiliate. This subparagraph 5(g) shall not be construed to extend the term of any option or to permit anyone to exercise the option after expiration of its term, nor shall it be construed to increase the number of shares as to which any option is exercisable from the amount exercisable on the date of termination of the optionee's employment or relationship as a consultant or director.
h. The option may, but need not, include a provision whereby the optionee may elect at any time during the term of his or her employment or relationship as a consultant or director with the Company or any Affiliate to exercise the option as to any part or all of the shares subject to the option prior to the stated vesting date of the option or of any installment or installments specified in the option. Any shares so purchased from any unvested installment or option may be subject to a repurchase right in favor of the Company or to any other restriction the Board or the Committee determines to be appropriate.
i. To the extent provided by the terms of an option, the optionee may satisfy any federal, state or local tax withholding obligation relating to the exercise of such option by any of the following means or by a combination of such means:
(1) tendering a cash payment;
(2) authorizing the Company to withhold from the shares of the common stock otherwise issuable to the participant as a result of the exercise of the stock option a number of shares having a fair market value less than or equal to the amount of the withholding tax obligation; or
(3) delivering to the Company owned and unencumbered shares of the common stock having a fair market value less than or equal to the amount of the withholding tax obligation.

6. COVENANTS OF THE COMPANY
a. During the terms of the options granted under the Plan, the Company shall keep available at all times the number of shares of stock required to satisfy such options.
b. The Company shall seek to obtain from each regulatory commission or agency having jurisdiction over the Plan such authority as may be required to issue and sell shares of stock upon exercise of the options granted under the Plan; provided, however, that this undertaking shall not require the Company to register under the Securities Act either the Plan, any option granted under the Plan or any stock issued or issuable pursuant to any such option. If, after reasonable efforts, the Company is unable to obtain from any such regulatory commission or agency the authority which counsel for the Company deems necessary for the lawful issuance and sale of stock under the Plan, the Company shall be

Page 4

relieved from any liability for failure to issue and sell stock upon exercise of such options unless and until such authority is obtained.

7. USE OF PROCEEDS FROM STOCK Proceeds from the sale of stock pursuant to options granted under the Plan shall constitute general funds of the Company.

8. MISCELLANEOUS
a. Neither an optionee nor any person to whom an option is transferred under subparagraph 5(d) shall be deemed to be the holder of, or to have any of the rights of a holder with respect to, any shares subject to such option unless and until such person has satisfied all requirements for exercise of the option pursuant to its terms.
b. Throughout the term of any option granted pursuant to the Plan, the Company shall make available to the holder of such option, not later than one hundred twenty (120) days after the close of each of the Company's fiscal years during the option term, upon request, such financial and other information regarding the Company as comprises the annual report to the stockholders of the Company provided for in the bylaws of the Company.
c. Nothing in the Plan or any instrument executed or option granted pursuant thereto shall confer upon any eligible employee or optionee any right to continue in the employ of the Company or any Affiliate (or to continue acting as a consultant or director) or shall affect the right of the Company or any Affiliate to terminate the employment or consulting relationship or directorship of any eligible employee or optionee with or without cause. In the event that an optionee is permitted or otherwise entitled to take a leave of absence, the Company shall have the unilateral right to
(i) determine whether such leave of absence will be treated as a termination of employment for purposes of paragraph 5(g) hereof and corresponding provisions of any outstanding options, and
(ii) suspend or otherwise delay the time or times at which the shares subject to the option would otherwise vest.

9. ADJUSTMENTS UPON CHANGES IN STOCK
a. If any change is made in the stock subject to the Plan, or subject to any option granted under the Plan (through merger, consolidation, reorganization, recapitalization, stock dividend, dividend in property other than cash, stock split, liquidating dividend, combination of shares, exchange of shares, change in corporate structure or otherwise), then the Plan and outstanding options shall be appropriately adjusted:
(1) in the class(es) and maximum number of shares subject to the Plan; and
(2) in the class(es) and number of shares and price per share of stock subject to outstanding options.
b. In the event of:
(1) a merger or consolidation in which the Company is not the surviving corporation; or
(2) a reverse merger in which the Company is the surviving corporation but the shares of the Company's common stock outstanding immediately preceding the merger are converted by virtue of the merger into other property, whether in the form of securities, cash or otherwise; then to the extent permitted by applicable law:
(i) any surviving corporation shall assume any Options outstanding under the Plan or shall substitute similar Options for those outstanding under the Plan, or
(ii) such Options shall continue in full force and effect. In the event any surviving corporation refuses to assume such Options, refuses to continue such Options in full force and effect, or refuses to substitute similar options for those outstanding under the Plan, then all such vested Options shall be terminated if not exercised prior to such event, and all such unvested Options shall terminate upon such event. In the event of a dissolution or liquidation of the Company, all vested Options outstanding under the Plan shall terminate if not exercised prior to such event, and all unvested Options outstanding under the Plan shall terminate upon such event.

10. AMENDMENT OF THE PLAN
a. The Board at any time, and from time to time, may amend the Plan. However, except as provided in paragraph 9 relating to adjustments upon changes in stock, no

Page 5

amendment shall be effective unless approved by the stockholders of the Company to the extent stockholder approval is necessary for the Plan to satisfy the requirements of Rule 16b-3 under the Exchange Act or any Nasdaq or securities exchange listing requirements.
b. It is expressly contemplated that the Board may amend the Plan in any respect the Board deems necessary or advisable to provide optionees with the maximum benefits provided or to be provided under the provisions of the Code and the regulations promulgated thereunder relating to employee incentive stock options and/or to bring the Plan and/or incentive stock options granted under it into compliance therewith.
c. Rights and obligations under any option granted before amendment of the Plan shall not be altered or impaired by any amendment of the Plan unless
(i) the Company requests the consent of the person to whom the option was granted and
(ii) such person consents in writing.

11. TERMINATION OR SUSPENSION OF THE PLAN
a. The Board may suspend or terminate the Plan at any time. Unless sooner terminated, the Plan shall terminate ten (10) years from the date the Plan is adopted by the Board or approved by the shareholders of the Company, whichever is earlier. No options may be granted under the Plan while the Plan is suspended or after it is terminated.
b. Rights and obligations under any option granted while the Plan is in effect shall not be altered or impaired by suspension or termination of the Plan, except with the consent of the person to whom the option was granted.

12. EFFECTIVE DATE OF PLAN The Plan shall become effective as determined by the Board, but no options granted under the Plan shall be exercised unless and until the Plan has been approved by the stockholders of the Company, and, if required, an appropriate permit has been issued by the Commissioner of Corporations of the State of California.

ADOPTED BY THE BOARD OF DIRECTORS ON JULY 17, 1990 APPROVED BY THE STOCKHOLDERS ON JULY 23, 1990 AMENDED BY THE BOARD OF DIRECTORS ON OCTOBER 3, 1990 AMENDED BY THE BOARD OF DIRECTORS ON MARCH 14, 1992 APPROVED BY THE STOCKHOLDERS ON MARCH 23, 1992 AMENDED BY THE BOARD OF DIRECTORS ON JUNE 18, 1992 AMENDED BY THE STOCKHOLDERS ON SEPTEMBER 2, 1993 AMENDED BY THE BOARD OF DIRECTORS ON DECEMBER 18, 1996 AMENDED BY THE STOCKHOLDERS ON JANUARY 31, 1997

Page 6

1996 NON-EMPLOYEE DIRECTORS'
STOCK OPTION PLAN

1. PURPOSE

a. The purpose of the Valence Technology, Inc. 1996 Non-Employee Directors' Stock Option Plan ("Plan") is to provide a means by which each director of Valence Technology, Inc., a Delaware corporation ("Company") who is not otherwise an employee of the Company or of any Affiliate of the Company (each such person being hereinafter referred to as a "Non-Employee Director") will be given an opportunity to purchase stock of the Company.
b. The word "Affiliate" as used in the Plan means any parent corporation or subsidiary corporation of the Company as those terms are defined in Sections 424(e) and (f), respectively, of the Internal Revenue Code of 1986, as amended from time to time ("Code").
c. The Company, by means of the Plan, seeks to retain the services of persons now serving as Non-Employee Directors of the Company, to secure and retain the services of persons capable of serving in such capacity, and to provide incentives for such persons to exert maximum efforts for the success of the Company.

2. ADMINISTRATION
a. The Plan shall be administered by the Board of Directors of the Company ("Board") unless and until the Board delegates administration to a committee, as provided in subparagraph 2.b.
b. The Board may delegate administration of the Plan to a committee composed of not fewer than two (2) members of the Board ("Committee"). If administration is delegated to a Committee, the Committee shall have, in connection with the administration of the Plan, the power theretofore possessed by the Board, subject, however, to such resolutions, not inconsistent with the provisions of the Plan, as may be adopted from time to time by the Board. The Board may abolish the Committee at any time and revest in the Board the administration of the Plan.

3. SHARES SUBJECT TO THE PLAN
a. The stock that may be sold pursuant to options granted under the Plan shall not exceed in the aggregate two hundred fifty thousand (250,000) shares of the Company's common stock. If any option granted under the Plan shall for any reason expire or otherwise terminate without having been exercised in full, the stock not purchased under such option shall again become available for the Plan.
b. The stock subject to the Plan may unissued shares or reacquired shares, bought on the market or otherwise.

4. ELIGIBILITY Options shall be granted only to Non-Employee Directors of the Company.

5. NON-DISCRETIONARY GRANTS
a. Each person who is, after the Effective Date, elected for the first time to be a Non-Employee Director automatically shall, upon the date of initial election to be a Non-Employee Director by the Board or Stockholders of the Company, be granted an option to purchase one hundred thousand (100,000) shares of common stock of the Company on the terms and conditions set forth herein. The exercise price of each such option shall be equal to the last sale price per share of the Company's Common Stock on the National Market of the Nasdaq Stock Market on the date of the grant as reported in THE WALL STREET JOURNAL, which the Board hereby determines, after consideration of all relevant factors, to be equal to the fair market value of the Company's Common Stock on the date hereof, and this option shall become exercisable according to one-fifth vesting on the date of the first and second anniversary of the date the Non-Employee Director was elected to the Board and one-twentieth quarterly vesting over the remaining three (3) year vesting schedule, with vesting to begin on the date of the grant, and the appropriate officers of the Company are hereby authorized and directed to execute an option agreement with the foregoing optionee in the form approved by the Board for use with the Plan, as well as any and all other documents

Page 1

convenient or proper to carry the foregoing option into effect, and to perform the commitments of the Company upon the exercise of such option, including but not limited to the sale and issuance of the shares covered by such options.
b. On the Effective Date of the Plan, each person who is, as of that date, a Non-Employee Director who has never before been granted an option by the Company, automatically shall be granted an option to purchase one hundred thousand (100,000) shares of common stock of the Company. The exercise prices and vesting schedule shall be determined as described in section 5.a., above.
c. On the anniversary of a Non-Employee Director's election to the Board (or the anniversary of the Effective Date of the Plan for a Non-Employee Director who received a stock option under section 5.b., above), the Non-Employee Director shall be granted an option to purchase shares of the Company's common stock. The number of shares subject to such option shall be equal to one hundred thousand (100,000) less the number of unvested shares subject to options granted to the Non-Employee Director by the Company. The exercise price shall be determined as described in section 5.a., above. This option shall be become exercisable according to one-twelfth quarterly vesting over a three (3) year vesting period, with vesting to begin on the date of the grant.

6. OPTION PROVISIONS
a. The term of each option commences on the date it is granted and, unless sooner terminated as set forth herein, expires on the date ("Expiration Date") ten (10) years from the date of grant. If the optionee's service as a Non-Employee Director or employee of or Consultant to the Company or any Affiliate terminates for any reason or for no reason, the option shall terminate on the earlier of the Expiration Date or the date twelve (12) months following the date of termination of all such service; provided, however, that if such termination of service is due to the optionee's death, the option shall terminate on the earlier of the Expiration Date or eighteen (18) months following the date of the optionee's death. In any and all circumstances, an option may be exercised following termination of the optionee's service as a Non-Employee Director, or employee of, or consultant, to the Company, or any Affiliate, only as to that number of shares as to which it was exercisable on the date of termination of such service.
b. Payment of the exercise price of each option is due in full in cash upon any exercise when the number of shares being purchased upon such exercise is one thousand (1,000) shares or less. However, when the number of shares being purchased upon as exercise is more than one thousand (1,000) shares, the optionee may elect to make payment of the exercise price under one of the following alternatives:
i. payment of the exercise price per share in cash or by check at the time of exercise;
ii. provided that at the time of the exercise the Company's common stock is publicly traded and quoted regularly in the Wall Street Journal, payment by delivery of shares of common stock of the Company already owned by the optionee, held for the period required to avoid a charge to the Company's reported earnings, and owned free and clear of any liens, claims, encumbrances or security interest, which common stock shall be valued at its fair market value on the date preceding the date of exercise; or
iii. payment by a combination of the methods of payment specified in sections 6.b.i and 6.b.ii, above. Notwithstanding the foregoing, this option may be exercised pursuant to a program developed under Regulation T as promulgated by the Federal Reserve Board which results in the receipt of cash (or check) by the Company prior to the issuance of shares of the Company's common stock.
c. A option may be transferred to the extent provided in the option agreement; provided that if the option agreement does not expressly permit the transfer of a option, the option shall not be transferable except by will, by the laws of descent and distribution or pursuant to a domestic relations order satisfying the requirements of Rule 16b-3, and shall be exercisable during the lifetime of the person to whom the option is granted only by such person or any transferee pursuant to a domestic relations order. Notwithstanding the foregoing, the person to whom the option is granted may, be delivering written notice to the Company, in a form satisfactory to the Company, designate a third party who, in the event of the death of the optionee, shall thereafter be entitled to exercise the option.

Page 2

d. The minimum number of shares with respect to which this option may be exercised at any one time is one thousand (1,000), except (a) as to an installment subject to exercise, as set forth in paragraph 1, which amounts to fewer than one thousand (1,000) shares, in which case, as to the exercise of that installment, the number of such shares in such installment shall be the minimum number of shares, and (b) with respect to the final exercise of this option this minimum shall not apply. In no event may this option be exercised for any number of shares which would require the issuance of anything other than whole shares.
e. The Company may require any optionee, or any person to whom an option is transferred under subparagraph 6(d), as a condition of exercising any such option:
i. to give written assurances satisfactory to the Company as to the optionee's knowledge and experience in financial and business matters; and
ii. to give written assurances satisfactory to the Company stating that such person is acquiring the stock subject to the option for such person's own account and not with any present intention of selling or otherwise distributing the stock. These requirements, and any assurances given pursuant to such requirements, shall be inoperative if the issuance of the shares upon the exercise of the option has been registered under a then-currently-effective registration statement under the Securities Act of 1933, as amended (the "Securities Act"), or as to any particular requirement, a determination is made by counsel for the Company that such requirement need not be met in the circumstances under the then applicable securities laws.
f. Notwithstanding anything to the contrary contained herein, an option may not be exercised unless the shares issuable upon exercise of such option are then registered under the Securities Act or, if such shares are not then so registered, the Company has determined that such exercise and issuance would be exempt from the registration requirements of the Securities Act.

7. COVENANTS OF THE COMPANY
a. During the terms of the option granted under the Plan, the Company shall keep available at all times the number of shares of stock required to satisfy such options.
b. The Company shall seek to obtain from each regulatory commission or agency having jurisdiction over the Plan such authority as may be required to issue and sell shares of stock upon exercise of the options granted under the Plan; provided, however, that this undertaking shall not require the Company to register under the Securities Act either the Plan, any option granted under the Plan, or any stock issued or issuable pursuant to any such option. If, after reasonable efforts, the Company is unable to obtain from any such regulatory commission or agency the authority which counsel for the Company deems necessary for the lawful issuance and sale of stock under the Plan, the Company shall be relieved from any liability for failure to issue and sell stock upon exercise of such options.

8. USE OF PROCEEDS FROM STOCK Proceeds from the sale of stock pursuant to options granted under the Plan shall constitute general funds of the Company.

9. MISCELLANEOUS
a. Neither an optionee nor any person to whom an option is transferred under section 6.c shall be deemed to be the holder of, or to have any of the rights of a holder with respect to, any shares subject to such option unless and until such person has satisfied all requirements for exercise of the Option pursuant to its terms.
b. Nothing in the Plan or in any instrument executed pursuant thereto shall confer upon any Non-Employee Director any right to continue in the service of the Company or any Affiliate or shall affect any right of the Company, its Board or stockholders or any Affiliate to terminate the service of any Non-Employee Director with or without cause.
c. No Non-Employee Director, individually or as a member of a group, and no beneficiary or other person claiming under or through him, shall have any right, title or interest in or to any option reserved for the purposes of the Plan except as to such shares of common stock, if any, as shall have been reserved for him pursuant to an option granted to him.
d. In connection with each option made pursuant to the Plan, it shall be a condition precedent to the Company's obligation to issue or transfer shares to a Non-Employee Director, or to evidence the removal of any restrictions on transfer, that such Non-Employee Director make arrangements satisfactory to the Company to insure that the amount of any

Page 3

federal or other withholding tax required to be withheld with respect to such sale or transfer, or such removal or lapse, is made available to the Company for timely payment of such tax.

10. ADJUSTMENTS UPON CHANGES IN STOCK
a. If any change is made in the stock subject to the Plan, or subject to any option granted under the Plan (through merger, consolidation, reorganization, recapitalization, reincorporation, stock dividend, dividend in property other than cash, stock split, liquidating dividend, combination of shares, exchange of shares, change in corporate structure or otherwise), the Plan and outstanding options will be appropriately adjusted in the class(es) and maximum number of shares subject to the Plan and the class(es) and number of shares and price per share of stock subject to outstanding options.
b. In the event of:
i. a dissolution, liquidation or sale of substantially all of the assets of the Company;
ii. a merger or consolidation in which the Company is not the surviving corporation;
iii. a reverse merger in which the Company is the surviving corporation but the shares of the Company's common stock outstanding immediately preceding the merger are converted by virtue of the merger into other property, whether in the form of securities, cash or otherwise; or
iv. any other capital reorganization (including a sale of stock of the Company to a single purchaser or single group of affiliated purchasers) after which less than fifty percent (50%) of the Outstanding voting shares of the new or continuing corporation are owned by shareholders of the Company immediately before such transaction; options under the Plan shall immediately become fully vested and the time during which options outstanding under the Plan may be exercised shall be accelerated to permit the optionee to exercise all such options In full prior to such event, and the options shall terminate if not exercised prior to such event.

11. AMENDMENT OF THE PLAN
a. The Board at any time, and from time to time, may amend the Plan. However, except as provided in paragraph 10 relating to adjustments upon changes in stock, no amendment shall be effective unless approved by the stockholders of the Company to the extent stockholder approval is necessary for the Plan to satisfy the requirements of Rule 16b-3 under the Exchange Act or any Nasdaq or securities exchange listing requirements.
b. Rights and obligations under any option granted before any amendment of the Plan shall not be impaired by such amendment unless:
i. the Company requests the consent of the person to whom the option was granted; and
ii. such person consents in writing.

12. TERMINATION OR SUSPENSION OF THE PLAN
a. The Board may suspend or terminate the Plan at any time. No options may be granted under the Plan while the Plan is suspended or after it is terminated.
b. Rights and obligations under any option granted while the Plan is in effect shall not be impaired by suspension or termination of the Plan, except with the consent of the person to whom the option was granted.

13. EFFECTIVE DATE OF THE PLAN; CONDITIONS OF EXERCISE
a. The Plan shall become effective on February 13, 1996 ("Effective Date"), provided that no options may be exercised unless and until the Plan is approved by stockholders of the Company.
b. No option granted under the Plan shall be exercised or exercisable unless and until the condition of subparagraph 13.a, above, has been met.

ADOPTED BY THE BOARD OF DIRECTORS ON FEBRUARY 13, 1996 AMENDED BY THE BOARD OF DIRECTORS ON DECEMBER 18, 1996 APPROVED BY THE STOCKHOLDERS ON JANUARY 31, 1997

Page 4

ARTICLE 5


PERIOD TYPE 9 MOS
FISCAL YEAR END MAR 31 1997
PERIOD START SEP 30 1996
PERIOD END DEC 29 1996
CASH 32,900
SECURITIES 6,420
RECEIVABLES 577
ALLOWANCES 0
INVENTORY 0
CURRENT ASSETS 40,365
PP&E 27,900
DEPRECIATION (15,515)
TOTAL ASSETS 57,837
CURRENT LIABILITIES 10,417
BONDS 5,091
PREFERRED MANDATORY 0
PREFERRED 0
COMMON 140,338
OTHER SE (99,063)
TOTAL LIABILITY AND EQUITY 57,837
SALES 0
TOTAL REVENUES 0
CGS 0
TOTAL COSTS 0
OTHER EXPENSES (4,802)
LOSS PROVISION 0
INTEREST EXPENSE (139)
INCOME PRETAX (4,802)
INCOME TAX 0
INCOME CONTINUING (4,802)
DISCONTINUED 0
EXTRAORDINARY 0
CHANGES 0
NET INCOME (4,802)
EPS PRIMARY (0.22)
EPS DILUTED (0.22)


Globe24h | Business | 中国 | Danmark | Deutschland | España | France | Italia | 日本 | Magyarország | Nederland | Norge | Polska | Portugal | România | Dezvăluiri

Privacy Policy